Impaired Glucose Metabolisms of Patients with Obstructive Sleep Apnea and Type 2 Diabetes
Table 3
Baseline characteristics of T2DM.
Parameters
Mild-to-moderate OSA ()
Severe OSA ()
Duration of T2DM (months)
36.00 (24.00, 60.00)
36.00 (18.00, 114.00)
0.497
Therapies
Diet and exercise
1 (14.29)
2 (15.38)
0.730
Oral antidiabetic agents
2 (28.57)
4 (30.77)
0.664
Insulin
3 (42.85)
5 (38.47)
0.608
Oral antidiabetic agents and insulin
1 (14.29)
2 (15.38)
0.730
Chronic complications
Macrovascular complication
2 (28.57)
5 (38.47)
0.526
Nephropathy
3 (42.85)
1 (7.69)
0.101
Retinopathy
2 (28.57)
0 (0)
0.111
Neuropathy
1 (14.29)
3 (23.08)
0.561
Continuous data with nonnormal distribution are presented as median (first quartile, third quartile), and noncontinuous data are presented as number (%).